• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠和人血清及血浆中的钙化抑制剂

Calcification inhibitors in rat and human serum and plasma.

作者信息

Meyer J L, Fleisch H

出版信息

Biochim Biophys Acta. 1984 Jun 15;799(2):115-21. doi: 10.1016/0304-4165(84)90284-8.

DOI:10.1016/0304-4165(84)90284-8
PMID:6329313
Abstract

Rat and human serum and plasma were shown to contain considerable amounts of calcium phosphate precipitation inhibitors. Two general classes of inhibiting molecules were observed for both species: high molecular weight (approx. 30 000-200 000) and low molecular weight (less than 1000). The high molecular weight components eluted from a Bio-Gel P-200 column in two peaks, one at approx. 158 000 and a broader peak at approx. 43 000. The identity of these inhibitors is unknown at present. Low molecular weight inhibitors include magnesium, pyrophosphate, and citrate ions and at least one unidentified component that coelutes with pyrophosphate and citrate on a Bio-Gel P-4 column. Quantitatively, most of the inhibitor activity resides in the high molecular weight components and it is possible that it is this activity which is responsible for maintaining the metastability of the circulating fluids. The role of the low molecular weight components may be to regulate calcification at sites inaccessible to high molecular weight molecules.

摘要

已证明大鼠和人类的血清及血浆中含有大量磷酸钙沉淀抑制剂。在这两个物种中均观察到两类抑制分子:高分子量(约30000 - 200000)和低分子量(小于1000)。从Bio - Gel P - 200柱上洗脱的高分子量组分出现两个峰,一个在约158000处,另一个较宽的峰在约43000处。目前这些抑制剂的具体成分尚不清楚。低分子量抑制剂包括镁离子、焦磷酸根离子和柠檬酸根离子,以及至少一种在Bio - Gel P - 4柱上与焦磷酸根和柠檬酸根共洗脱的未鉴定成分。从数量上看,大部分抑制活性存在于高分子量组分中,可能正是这种活性维持了循环液的亚稳定性。低分子量组分的作用可能是在高分子量分子无法到达的部位调节钙化。

相似文献

1
Calcification inhibitors in rat and human serum and plasma.大鼠和人血清及血浆中的钙化抑制剂
Biochim Biophys Acta. 1984 Jun 15;799(2):115-21. doi: 10.1016/0304-4165(84)90284-8.
2
Determination of calcium phosphate inhibitor activity. Critical assessment of the methodology.
Miner Electrolyte Metab. 1984;10(4):249-58.
3
Production of calcification inhibitors by rat calvaria and bone cells in culture.大鼠颅骨和培养的骨细胞产生钙化抑制剂。
Clin Orthop Relat Res. 1988 Jul(232):119-26.
4
Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. I. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium phosphate crystal growth.痕量金属 - 柠檬酸配合物作为钙化和晶体生长的抑制剂。I. Fe(III)、Cr(III) 和 Al(III) 配合物对磷酸钙晶体生长的影响。
J Urol. 1982 Dec;128(6):1372-5. doi: 10.1016/s0022-5347(17)53510-7.
5
Measurement of inhibitors of calcium phosphate precipitation in plasma ultrafiltrate.血浆超滤液中磷酸钙沉淀抑制剂的测定。
Am J Physiol. 1984 May;246(5 Pt 2):F648-55. doi: 10.1152/ajprenal.1984.246.5.F648.
6
Ion association. VI. Interactions between calcium, magnesium, inorganic phosphate, citrate and protein in normal human plasma.离子缔合。VI. 正常人血浆中钙、镁、无机磷酸盐、柠檬酸盐与蛋白质之间的相互作用。
J Clin Invest. 1961 Apr;40(4):723-30. doi: 10.1172/JCI104306.
7
Isolation of a low molecular weight glycoprotein inhibitor of calcium phosphate precipitation from the extra-parotid saliva of macaque monkeys.从猕猴腮腺外唾液中分离出一种低分子量磷酸钙沉淀糖蛋白抑制剂。
Arch Oral Biol. 1979;24(2):85-9. doi: 10.1016/0003-9969(79)90054-2.
8
Antagonists of bacitracin.杆菌肽拮抗剂。
Lett Appl Microbiol. 1994 Aug;19(2):102-4. doi: 10.1111/j.1472-765x.1994.tb00916.x.
9
Role of matrix vesicles in calcification.
Fed Proc. 1976 Feb;35(2):169-71.
10
[Gel model for measuring crystallization inhibitor activity].[用于测量结晶抑制剂活性的凝胶模型]
Z Urol Nephrol. 1982 Oct;75(10):689-98.

引用本文的文献

1
Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.碱性磷酸酶替代治疗在发育和实践中的低磷酸酶血症。
Adv Exp Med Biol. 2019;1148:279-322. doi: 10.1007/978-981-13-7709-9_13.
2
Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.阿法骨化醇治疗低磷性骨软化症的概况:设计、研发及治疗地位
Drug Des Devel Ther. 2018 Sep 24;12:3147-3161. doi: 10.2147/DDDT.S154922. eCollection 2018.
3
Calcium phosphate saturation levels in ultrafiltered serum.超滤血清中的磷酸钙饱和度水平
Calcif Tissue Int. 1987 Feb;40(2):71-8. doi: 10.1007/BF02555708.
4
The effects of serum and human albumin on calcium hydroxyapatite crystal growth.血清和人白蛋白对羟基磷灰石晶体生长的影响。
Biochem J. 1990 Mar 15;266(3):863-8.
5
Competitive adsorption of magnesium and calcium ions onto synthetic and biological apatites.镁离子和钙离子在合成磷灰石及生物磷灰石上的竞争吸附作用
Calcif Tissue Int. 1992 Aug;51(2):143-50. doi: 10.1007/BF00298503.